Rating History for Candel Therapeutics Inc. (CADL) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for CADL
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/21/2026 Alec Stranahan Upgrade Buy
(Neutral)		 18.00
(12.00)		 10.85
(8.19)		 -24.52% Details